Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open, Multi-centre Study to Assess the Safety and Tolerability of RGTA® (OTR4132) in Patients With Acute Ischemic Stroke (AIS)

NCT04083001 is registered in ClinicalTrials.gov with Organ, Tissue, Regeneration, Repair and Replacement as lead sponsor.

NCT NCT04083001
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04083001 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open, Multi-centre Study to Assess the Safety and Tolerability of RGTA® (OTR4132) in Patients With Acute Ischemic Stroke (AIS)
Lead sponsor
Organ, Tissue, Regeneration, Repair and Replacement
Phase
Not applicable
Overall status
Completed
Start date
March 3, 2022
Completion date
June 19, 2024
Enrollment
19 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

stroke, acute